AEYE Health is an AI technology for the detection of retinal conditions to prvent blindness and save lives. It provides an automated diagnostic screening solution that can revolutionize the scanning process and make it more accessible for patients.
The Problem: Diabetic retinopathy, glaucoma, age-related macular degeneration (AMD) among others are the leading causes of vision loss. Over 1 billion high risk people need an annual check (72 million in the USA). Less than 25% are screened due to the cost and impracticality of current solutions.
The Solution: AEYE has produced the first FDA-cleared, accurate, camera agnostic broad screening solution using compact, affordable and easy to operate handheld fundus cameras. These cameras provide advanced algorithms with proven results.
Watch an Intro to AEYE Health video here.
AEYE Health in the news:
November 2022 – FIBA company, Aeye Health, receives FDA clearance
April 2021 “UMass Medical School and AEYE Health Leverage AI to Help Family Doctors Screen and Refer Patients With Eye Conditions to Specialists” – Eyewire News
August 2020 “AEYE Health’s Simple Eye Scan to Diagnose, Prevent Avoidable Blindness” – No Camels